- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0002451

Pristino Pharma Private Limited
About Pristino Pharma Private Limited
Data last updated:
Pristino Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24304PN2020PTC190907. Its GSTIN is 27AALCP1484B1ZG (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Swapnila Vivek Shinde and Vivek Madhukar Shinde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 48/2 Ashoka Classic Flat B 05 Dnyanesh Park Pimgurav, Pune, Maharashtra, India – 411061.
As per the financials filed for FY 2023, the company reported a revenue of ₹64,000, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹4.22 Lakh and EBITDA of -₹4.17 Lakh.
Pristino Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0002451).
Company details
Recognitions & Rankings of Pristino Pharma
Contact details
Pristino Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address48/2 Ashoka Classic Flat B 05 Dnyanesh Park Pimgurav, Pune, Maharashtra, India – 411061
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pristino Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pristino Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pristino Pharma Private Limited, buy the company report.
Financials of Pristino Pharma Private Limited
FY 2025 filings availablePristino Pharma Private Limited reported revenue of ₹64,000 (down 35% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 35% in the latest year. EBITDA fell 98% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹4.17 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹4.22 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Pristino Pharma Private Limited, buy the company report.
Board of directors of Pristino Pharma Private Limited
Pristino Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnila Vivek Shinde Also directs: Vmcube Labs Private Limited | Director | 23 May 2020 | 6 Years 5 Months | Current |
| Vivek Madhukar Shinde Also directs: Watermark Insights India Private Limited | Director | 23 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Pristino Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shangrila Intermediaries Private Limited | ₹64,132 (FY 2025) | -76.0% | Hyderabad, Telangana, India | |||
| Thought Balloon Private Limited | ₹64,122 (FY 2025) | -47.0% | Delhi, India | |||
| Prema Natural Fur Private Limited | ₹64,122 (FY 2018) | 68.0% | Delhi, India | |||
| Vibrant Marketing Private Limited | ₹64,094 (FY 2025) | -100.0% | Chennai, Tamil Nadu, India | |||
| Nextfresh Industries Private Limited | ₹64,010 (FY 2025) | 24.0% | Agra, Uttar Pradesh, India | |||
| Pristino Pharma Private Limitedthis company | ₹64,000 (FY 2023) | -₹4.22 Lakh | -35.0% | Pune, Maharashtra, India | ||
| MG Education Academy (OPC) Private Limited | ₹64,000 (FY 2019) | 11.0% | Jaipur, Rajasthan, India | |||
| Tehan Trinity Private Limited | ₹63,970 (FY 2025) | -38.0% | Dibrugarh, Assam, India | |||
| Bhole Baba Overseas Private Limited. | ₹63,960 (FY 2024) | 3.0% | New Delhi, Delhi, India | |||
| Essential Food Services(Tefco) Private Limited | ₹63,950 (FY 2024) | 419.0% | Kozhencherry, Kerala, India | |||
| Netula Laboratories Private Limited | ₹63,927 (FY 2023) | New Delhi, Delhi, India |
To see the full peer comparison of Pristino Pharma Private Limited, buy the company report.
Auditor
Pristino Pharma Private Limited is audited by ARCHANA DHAMECHA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARCHANA DHAMECHA & ASSOCIATES | FY 2022 | 135654W |
Shareholding
The shareholding of Pristino Pharma Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Pristino Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pristino Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pristino Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pristino Pharma Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Pristino Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCP1484B1ZG | Maharashtra | Active | 14 Jul 2020 |
To see the full GST registrations and return filing status of Pristino Pharma Private Limited, buy the company report.
Recent activity
Pristino Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Swapnila Vivek Shinde was appointed as Director on 23 May 2020.
Frequently asked questions
Pristino Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 May 2020 (6+ years old) and is registered under CIN U24304PN2020PTC190907.
Pristino Pharma has 2 current directors:
- Swapnila Vivek Shinde - Director
- Vivek Madhukar Shinde - Director
The latest financial statements of Pristino Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Pristino Pharma is 27AALCP1484B1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pristino Pharma is U24304PN2020PTC190907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pristino Pharma was incorporated on 23 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Pristino Pharma by revenue are Shangrila Intermediaries Private Limited, Thought Balloon Private Limited, Prema Natural Fur Private Limited, Vibrant Marketing Private Limited, Nextfresh Industries Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Swapnila Vivek Shinde was appointed as Director on 23 May 2020. Vivek Madhukar Shinde was appointed as Director on 23 May 2020.
Yes, Pristino Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0002451).
The registered office of Pristino Pharma is at 482 Ashoka Classic Flat B 05 Dnyanesh Park Pimgurav, Pune, Maharashtra, India – 411061.
Pristino Pharma operates in the pharma industry, in the drug formulation and development segment.

